1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow GRF312 5%: new trials by email Literature Review of GRF312 5% trials Research Report on GRF312 5%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). GRF312 5%, Placebo Comparator - Dry Eye Disease | Phase 2 | Completed | Instituto Grifols, S.A. | 103 | 2025-11-03 | 2026-06-16 |
Autoimmune Diseases (1) · Dry Eye Syndromes (1)
United States (1)